New study reveals that industry-sponsored research on unprocessed meat consumption often downplays health risks, highlighting the impact of COl in scientific findings. Plus most used inappropiate comparators biasing results in favor of meat www.sciencedirect.com/science/arti...

How could a more sustainable #IBD practice be? We are willing to answer this question for which we would love if you could fill this 5-min questionnaire if you are an IBD clinician forms.gle/EtaMUjGPn14K...

🚨 The countdown is getting real! 🚨 Only three days until registration for #UEGWeek 2025 opens. Are you ready to dive into the world of gastroenterology with the brightest minds around? Don’t miss out on your chance to be part of this congress, Oct 4 - 7 in Berlin! 3️⃣➡️ https://bit.ly/3fmrWyu

Chronic myeloid leukemia is a myeloproliferative neoplasm. This Review summarizes the epidemiology, diagnosis, and management of chronic myeloid leukemia. https://ja.ma/3FByjLx

We are counting down: ONLY 5 DAYS TO GO 🎉 until registration for #UEGWeek 2025 in Berlin kicks off! 🚀 Are you ready to be part of the best gastroenterology gathering this year? Mark your calendars & set your alarms! 🌍💪 5️⃣➡️ https://bit.ly/3fmrWyu

I started a list of our titles that I’m updating as more join - bsky.app/profile/did:...

If you don’t get your child vaccinated against measles, it can put them at a high risk of this serious infection, which can lead to severe complications or even death. Make sure your child’s measles vaccination is up to date.

18.5% of patients who left the emergency department without being seen returned within 7 days, often due to difficulties in accessing non-ED care. ja.ma/3DrJMwu #MedSky

Help drive meaningful change within UEG and beyond: as a Young Talent Group member, you’ll have the opportunity to actively contribute to initiatives that create a more inclusive and diverse GI community. Apply by March 13: https://bit.ly/3p0zyJo #myUEGcommunity #weareUEG

Who funds biomedical research? @nature.com www.nature.com/articles/d41...

Grateful to have worked with this amazing team on this project! To curb the rapid rise of #IBD, we must understand both risk & protective factors Our latest research explores key environmental influences to guide prevention strategies academic.oup.com/ecco-jcc/adv...

👩‍⚕️🌍 Today, on International Women's Day, we celebrate the passion, resilience, and groundbreaking contributions of women in gastroenterology! At UEG, we are committed to fostering an inclusive environment where all talents thrive. Let’s keep breaking barriers together! 💚 #UEGWomeninGI

Time turns people into legends 1/🧵 on one of the most important women in med history: Gertrude B. Elion You may not know her, but her discoveries changed medicine She co-developed thiopurines (azathioprine, mercaptopurine), a breakthrough in immunosuppressive therapy, & won the Nobel Prize in 1988

In the 📕#RedJournal: Diagnosis and Management of Clostridioides difficile in Inflammatory Bowel Disease Byron P. Vaughn, MD, MS; Alexander Khoruts, MD & Monika Fischer, MD, MSc, FACG 👉 bit.ly/3EYVbEp

This is wild. Tasting things virtually www.science.org/doi/10.1126/... Front page @nytimes.com www.nytimes.com/2025/02/28/s...

3 points of progress vs pancreatic cancer! 1. Neoantigen vaccines www.nature.com/articles/s41... 2. KRAS drugs www.wsj.com/health/healt... 3. Early diagnosis www.science.org/doi/10.1126/...

#WeekendRead! #WeAreWhatWeEat! Lesbats, Garaude &co show @nature.com that macrophages recycle phagocytosed bacteria to fuel their metabolism but that dead, compared to live, bacteria still feed macrophages but reduce the induction of ROS & the secretion of IL1b! www.nature.com/articles/s41...

🔎Strictures in Crohn's disease can be challenging to manage I've put together a summary on different approaches and an infographic on strictureplasties Patients want to know about this, so I hope this can serve as an useful resource 🆕www.ibd-eii.com/ibdcheatsheet #IBD

🔎Strictures in Crohn's disease can be challenging to manage I've put together a summary on different approaches and an infographic on strictureplasties Patients want to know about this, so I hope this can serve as an useful resource 🆕www.ibd-eii.com/ibdcheatsheet #IBD

Wrapping up February with the latest updates on www.ibd-eii.com ! This month's newsletter, coming this evening, includes new triss and #IBD cheatsheets! Some interesting research, like this one on hemorrhoid therapy in IBD (📷). Stay tuned!

As a UEG Young Talent Group member, you can have the chance to shape educational programmes and support the next generation of specialists! Learn more and apply by March 13: https://bit.ly/3p0zyJo 🌟 #myUEGcommunity #weareUEG @bealoquebea.bsky.social

Paradigm Shift in Inflammatory Bowel Disease Management: Precision Medicine, Artificial Intelligence, and Emerging Therapies Our latest publication www.mdpi.com/2077-0383/14...

It was a pleasure to present our collaboration with PREDICT at #ECCO2025 last week. We demonstrate subgroups of IBD patients can be characterised by distinct FC and CRP profiles, validated independently in 🇩🇰. The preprint is available here: doi.org/10.1101/2024...

Adolescents after laparoscopic sleeve gastrectomy (N=12) ⬆️ microbial diversity Enrichment of Streptococcus&Actinomyces (oral-bacteria) ‼️⬆️ fecal calprotectin 6/8 patients(p=0.0016),5months post-op ?impact of bariatric surgery&IBD risk @gamonasterioo.bsky.social www.tandfonline.com/doi/full/10....

New personal view article How can the gut #microbiome be targeted to fight multidrug-resistant organisms? www.thelancet.com/journals/lan... #IDSky #ClinMicro #AMR #OpenAccess #OA

REScUE trial of patients with CD losing response to UST All patients received IV reinduction and then q4w SC vs q8w SC ❗️Primary outcome: SF clinical remission: PRO2 & FCP <250 & no steroids for 90 days before w48 ‼️Less than 20% met primary outcome #ECCO2025

Clusters of antibiotic use patterns after the first episode of pouchitis 4⃣ groups: rare intermittent > intermittent > chronic antibiotic-responsive > chronic antibiotic dependent antiTNF prior IPAA & antibióticos in the 12 months prior pouch formation associated with chronic pouchitis #ECCO2025

One that I am fond of as a reality check when we have multiple and varying endpoints - VWF tells us what the participants actually think of the trial drug.

Phase 1b study of SOR102, orally delivered bispecific anti-TNF/anti-IL-23 domain antibody in mild to severe UC !! Phase 1b very small N so caution with interpretation It surprised me the fact that it includes also patients with mild #UC? giving a double acting #IBD #ECCO2025

Very nice tandem of @Iris_Dotan and Revital Barkan about how far should we pursue our targets to help patients live a normal life? ✅How fast should we act? FASTER & FURTHER ✅Stratify patients better ✅Multidisciplinary approach 🌍Address community gaps

Well, that never worked. Even the Takeda folks knew it was a dry well. More is not always better. If Vedo is not working, move on in #IBD. #ECCO2025 @bealoquebea.bsky.social

Duvakitug (TEV-48574) Anti-TL1A- RELIEVE UCCD trial Results from a Phase 2b trial #IBD #CD #ECCO2025

🚀 Are you passionate about shaping the future of gastroenterology? Join UEG’s Young Talent Group! Learn more and apply by March 13: https://bit.ly/3p0zyJo #myUEGcommunity #weareUEG

Over 400 million people globally are affected by alcohol use disorder. In @lancetgastrohep.bsky.social, a new Review explores the current management and treatment options for alcohol use disorder from a gastroenterology and hepatology-focused perspective: tinyurl.com/43fxj63f

Identifying patients with chronic hepatitis B who are a priority for antiviral therapy APRI >0·5 or FibroScan >7·0 kPa identifies most adults with significant fibrosis (≥F2) APRI >1·0 or FibroScan >12·5 kPa to identifies most adults with cirrhosis (F4) #HepSky #LiverSky #MedSky

The race to explain why more young adults are getting cancer #GastroSky #OncSky #MedSky

None better than @ibdseb.bsky.social to talk about underrepresented populations in #IBD research #ECCO2025 Difficult to choose the best slides, thanks Seb

School for Clinical trialist #ECCO2025 Starting by @J_Kirchgesner introducing how to set your path from the early days #ibd

How to organize an IBDD research Unit from Scratch by @SeverineVermei1 #ECC02025 #ibd

How to create a global consortium by @DrAilsaHart at #ECCO2025 Huge expertise with the perianal disease consortium Great to see how this has progressed from the first idea #ibd

Outstanding review by Nuru Noor revisiting the design of clinical trials #ECCO2025 #ibd

Getting your real-time heart rhythm monitored for 10 days now requires an ECG technician to review and notify your doctor of a critical arrhythmia. A new study showed A.I. did better than technicians (98.6% vs 80.3%) for identifying these abnormalities nature.com/articles/s41...

Mesalazine for periodontitis via regulation of periodontal microbiota and inhibiting Porphyromonas gingivalis I know @gamonasterioo.bsky.social will enjoy this read pmc.ncbi.nlm.nih.gov/articles/PMC...

Two years ago,I had a crazy idea I want to say thank you to everyone who saw a young girl believing in herself and chose to believe in her too 📈390k visits & more than 39k users.Reminder that science knows NO borders & we are all connected by the same passion & mission:to help others #ibd

Management of Necrotizing Acute ⚡️ Pancreatits in the modern era 🇺🇸 25K acute pancreatitis (20% necrotizing) 🪡 14% underwent procedural intervention 🏥 Low volume > open necrosectomy vs. MI / endoscopy 👍 High volume > improved survival / resources journals.lww.com/annalsofsurg... #SurgSky #HPBSky

FMT did not result in an improvement in lower gastrointestinal tract symptoms in patients with systemic sclerosis @thelancet.bsky.social #FMT www.thelancet.com/journals/lan...

Fantastic meeting of the Quality of Care committee of the UEG in Vienna 🤩

#WorldCancerDay is here! 🌍 Digestive cancers have increased by 26% between 2000-2019 in Europe, now causing 1/3 of cancer-related deaths. We need greater investment in prevention, treatment, and research funding to turn the tide. 💚🔬 Learn more ➡️ https://bit.ly/4g6TmSJ.#WorldCancerDay#EUNewsline

Meeting Brigida Barbeiro, someone I have admired for years for her work in #IBD thanks to @myueg.bsky.social

Who did this to @bealoquebea.bsky.social timeline?! ibd-eii.com/timeline/